Aug 2026· Biomolecules· Vol 16, pp. 1135· 1 citation· 41 references
Medicine
TL;DR
In vivo and in vitro experimental outcomes showed that QUE treatment effectively relieved abnormal cardiac function and myocardial fibrotic lesions and improved damaged mitochondrial morphology, and demonstrated that QUE confers cardioprotective effects against DIC within subacute rat models and cultured cardiomyocytes.
Abstract
Background: As a common clinical anticancer drug, doxorubicin (DOX) easily triggers obvious doxorubicin-induced cardiotoxicity (DIC) during clinical application. Accumulating evidence has proven that ferroptosis dominates the pathological process of DIC yet efficient targeted treatment strategies remain scarce. The present work mainly focused on clarifying the protective role of quercetin (QUE) against DIC. Methods: In vivo rat models and in vitro cardiomyocyte injury models were constructed to mimic DIC. Echocardiographic detection and histological staining were adopted to observe overall cardiac function and myocardial fibrotic changes. Ultrastructural alterations of intracellular mitochondria were observed under a transmission electron microscope. Relevant ferroptosis and oxidative stress levels were further determined. Moreover, a Western blot assay and NRF2 gene transfection technique were applied to confirm the involvement of the NRF2 signaling pathway. Results: In vivo and in vitro experimental outcomes showed that QUE treatment effectively relieved abnormal cardiac function and myocardial fibrotic lesions and improved damaged mitochondrial morphology. It also markedly restrained excessive iron accumulation and abnormal lipid peroxidation and restored disturbed redox balance in cardiomyocytes. Further mechanism exploration revealed that QUE could facilitate NRF2 entry into the cell nucleus and activate downstream SLC7A11/GPX4 signaling to maintain cellular glutathione homeostasis. Silencing NRF2 expression could fully reverse the above beneficial influences of QUE. Conclusions: Collectively, our experimental data demonstrated that QUE confers cardioprotective effects against DIC within subacute rat models and cultured cardiomyocyte injury models. Further mechanistic observations revealed that this protective phenotype is closely linked to the activation of NRF2/SLC7A11/GPX4 signaling alongside obvious reductions in multiple characteristic ferroptosis markers.
Doxorubicin (DOX)-induced cardiotoxicity (DIC) is a major limitation to the clinical use of DOX, highlighting the need for effective cardioprotective strategies. Although acteoside (ACT), a natural compound with antioxidant properties, has shown potential cardioprotective effects, its role in DIC, particularly in the r...
Meng Wang, Che Wang, Zhi-Hao Liu et al.· European Journal of Pharmaco...· 0 citations
BACKGROUND
Doxorubicin-induced cardiotoxicity (DIC) poses a substantial threat to the prognosis and survival of cancer patients. Ferroptosis, mediated in part by suppression of the SIRT1/NRF2 pathway, has been identified as a critical mechanism underlying DIC. Isoginkgetin (IGK), a naturally occurring biflavonoid with...
H. Mo, Han Su, Zhenyu Zhuang et al.· European Journal of Pharmaco...· 0 citations
The findings suggest that CAL acts as a dual-regulator of mitochondrial transcriptional machinery and iron metabolism, offering a novel therapeutic strategy to safeguard mitochondria against ferroptosis.
Huan Chen, Xi-Chen Li, Yi Yuan et al.· Antioxidants· 0 citations
DOX-induced cardiotoxicity reveals MFN1 as a key regulatory factor in DIC and provides a novel theoretical basis for its potential as a therapeutic target and inhibition of MFN1 significantly alleviates DIC injury.
J. Gao, M. Xue, Y. Zhangsun et al.· Molecular Biology· 0 citations
Collectively, CTRP4 attenuates DOX cardiotoxicity by suppressing oxidative stress and ferroptosis through the Sirt1/Nrf2 axis, highlighting its therapeutic potential for DOX-induced cardiac injury.
Jian Wang, Jie Zhang, Nan Wu et al.· Biochemical Pharmacology· 0 citations
Findings position DHQ as a promising candidate for protecting cardiomyocytes and endothelial cells from ATO-induced injury by activating the AMPK/SIRT1/PGC-1α pathway, thereby reducing oxidative stress and concurrently inhibiting apoptosis and ferroptosis.
Wen-Lei Zhang, Rui Duan, Xin-Sheng Duan et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.